TREK-1 is a background potassium channel, the protagonist in multiple key physiological functions and pathophysiological conditions in nervous and cardiovascular tissue including neuroprotection, depression, epilepsy, pain, ischemia, and atrial fibrillation (Djillani et al., 2019). This evidence concerns the gene KCNK2 and epilepsy.